Coronavirus Update: BIO Facilitates COVID-19 Collaborations, ASCO Goes Virtual

BIO hosts summit to support collaborations on coronavirus vaccines and therapeutics, Vir advances COVID-19 antibody candidates, Gilead renounces orphan status for remdesivir, BMS joins Pfizer in pushing back investor meeting, and ASCO goes virtual.  

Coronavirus globe

BIO has been working for the last several weeks to facilitate collaborations between biopharma companies that may be able to contribute vaccine, therapeutic or diagnostic know-how that may help detect, treat or prevent COVID-19, including an online summit hosted by the global industry organization on 24 and 25 March.

The government agency representatives, infectious disease experts and industry execs discussed government funds and other resources that are available to...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip